Hoellein, A., Fallahi, M., Schoeffmann, S., Steidle, S., Schaub, F. X., Rudelius, M., . . . Keller, U. (2014). Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma. American Society of Hematology.
Chicago-tyylinen lähdeviittausHoellein, Alexander, et al. Myc-induced SUMOylation Is a Therapeutic Vulnerability for B-cell Lymphoma. American Society of Hematology, 2014.
MLA-viiteHoellein, Alexander, et al. Myc-induced SUMOylation Is a Therapeutic Vulnerability for B-cell Lymphoma. American Society of Hematology, 2014.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.